Has Ravi Passi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,633,788 in general payments to Ravi Passi, MD across 530 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ravi Passi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ravi Passi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ravi Passi, MD

Internal Medicine · Rockville, MDNPI 1114921665

Payments from drug & device makers

$1,633,788in general payments, 2019–2025

Across 530 payments — averaging $3082.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Modernatx, Inc.$657K
Pfizer$554K
Genentech, Inc.$201K
Currax Pharmaceuticals LLC$122K
Exact Sciences$39K
AstraZeneca$36K
plus $25K from 42 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Modernatx, Inc.	124	$657,012
Pfizer	56	$553,618
Genentech, Inc.	54	$201,326
Currax Pharmaceuticals LLC	47	$121,699
Exact Sciences	21	$39,007
AstraZeneca	13	$35,656
GSK	8	$11,108
Merck	4	$9,985
Otsuka America Pharmaceutical, Inc.	15	$602
Novo Nordisk	22	$382
Boehringer Ingelheim	14	$376
Amgen	18	$369
Lilly USA, LLC	16	$321
Novartis	19	$309
Acadia Pharmaceuticals Inc	5	$252
Sunovion Pharmaceuticals Inc.	18	$250
UCB, Inc.	8	$188
Lundbeck LLC	6	$137
Astellas Pharma US Inc	6	$120
Biogen	4	$90
Johnson & Johnson	5	$89
Amarin Pharma, Inc.	5	$77
Abbott	4	$74
Dexcom, Inc.	2	$54
AbbVie(2 entities)	3	$52
Acorda Therapeutics, Inc	2	$45
Eisai Inc.	2	$44
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$42
Medtronic	2	$40
Sanofi Pasteur Inc.	2	$40
Gilead	2	$36
Sun Pharmaceutical Industries Inc.	2	$34
Bayer	2	$33
Cumberland Pharmaceuticals, Inc.	1	$32
Scilex Pharmaceuticals Inc.	2	$31
Avanir Pharmaceuticals, Inc.	2	$24
Alkermes, Inc.	1	$23
Xeris Pharmaceuticals, Inc.	1	$23
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$22
Collegium Pharmaceutical, Inc.	1	$22
Sumitomo Pharma America, Inc.	1	$22
Vivus LLC	1	$20
Ferring Pharmaceuticals Inc.	1	$20
IBSA Pharma Inc.	1	$18
E.r. Squibb & Sons, L.L.C.	1	$16
Linus Health, Inc.	1	$15
Neurocrine Biosciences, Inc.	1	$15
Biohaven Pharmaceutical Holding Company Ltd.	1	$15

How this compares

$1,633,788 in reported general payments places this provider in the 95th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland →

Medicare billing

Part B allowed, 2024

$276,147

Medicare patients

833

Services billed

3,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Rockville

Shishir KhetanRockville$52.1M
Jonathan CohenRockville$5M
Rahul PatelRockville$2.8M
Alan PollackRockville$2.1M
Padmaja MuthiahRockville$302K
Ira BergerRockville$228K
Michael SauriRockville$214K
David CharlesRockville$171K
Steven GellerElkridge$15.1M
Mary HowellHagerstown$6.2M

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →